These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11494452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Diagnosis in the myelodysplastic syndrome].
    Hunstein W, Ho AD.
    Dtsch Med Wochenschr; 1987 Jan 09; 112(2):60-2. PubMed ID: 3542464
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA.
    Scand J Haematol Suppl; 1986 Jan 09; 45():11-20. PubMed ID: 3515515
    [No Abstract] [Full Text] [Related]

  • 5. [Myelodysplastic syndromes].
    Sainty D, Horschowski N, Fossat C, Sampol J.
    Ann Biol Clin (Paris); 1985 Jan 09; 43(6):821-30. PubMed ID: 3914223
    [No Abstract] [Full Text] [Related]

  • 6. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S, Haus O.
    Pol Arch Med Wewn; 2005 Nov 09; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract] [Full Text] [Related]

  • 7. Classification of the myelodysplastic syndromes.
    Bennett JM.
    Clin Haematol; 1986 Nov 09; 15(4):909-23. PubMed ID: 3471370
    [No Abstract] [Full Text] [Related]

  • 8. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
    Leukemia; 1996 Jan 09; 10(1):20-6. PubMed ID: 8558932
    [Abstract] [Full Text] [Related]

  • 9. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
    Werner M, Maschek H, Kaloutsi V, Choritz H, Georgii A.
    Virchows Arch A Pathol Anat Histopathol; 1992 Jan 09; 421(1):47-52. PubMed ID: 1636249
    [Abstract] [Full Text] [Related]

  • 10. [Clarification of possible anemia].
    Uprichard J, Bain BJ.
    Praxis (Bern 1994); 2009 Dec 02; 98(24):1453-5. PubMed ID: 19953471
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
    Thiede T, Engquist L, Billström R.
    Eur J Haematol; 1988 Nov 02; 41(5):434-7. PubMed ID: 3208866
    [Abstract] [Full Text] [Related]

  • 14. Myelodysplastic syndromes: natural history and features of prognostic importance.
    Mufti GJ, Galton DA.
    Clin Haematol; 1986 Nov 02; 15(4):953-71. PubMed ID: 3552350
    [No Abstract] [Full Text] [Related]

  • 15. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F.
    Eur J Haematol; 2000 Feb 02; 64(2):71-9. PubMed ID: 10997326
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.
    Font P, Loscertales J, Benavente C, Bermejo A, Callejas M, Garcia-Alonso L, Garcia-Marcilla A, Gil S, Lopez-Rubio M, Martin E, Muñoz C, Ricard P, Soto C, Balsalobre P, Villegas A.
    Ann Hematol; 2013 Jan 02; 92(1):19-24. PubMed ID: 22948274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.